Quest Diagnostics Inc. Stock
Quest Diagnostics Inc. Stock
We can see a decrease in the price for Quest Diagnostics Inc.. Compared to yesterday it has lost -€2.200 (-1.410%).
With 11 Buy predictions and not the single Sell prediction the community is currently very high on Quest Diagnostics Inc..
With a target price of 173 € there is a slightly positive potential of 11.97% for Quest Diagnostics Inc. compared to the current price of 154.5 €.
Pros and Cons of Quest Diagnostics Inc. in the next few years
Pros
?
B****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
S********** s********
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Quest Diagnostics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Quest Diagnostics Inc. | -1.410% | -1.435% | -5.244% | 4.075% | 6.625% | 9.264% | 50.000% |
| Anthem Inc. | -0.330% | 7.746% | 8.204% | -15.353% | -13.118% | -39.669% | 19.112% |
| HCA Holdings Inc. | 0.490% | -1.196% | 1.003% | 38.511% | 43.767% | 79.171% | 217.469% |
| Universal Health Services B | -2.080% | -4.523% | -1.554% | 6.742% | 11.111% | 54.748% | 72.727% |
Comments
Quest Diagnostics (NYSE:DGX) had its "outperform" rating reaffirmed by analysts at Leerink Partners.
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics (NYSE:DGX) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Show more
Ratings data for DGX provided by MarketBeat
Quest Diagnostics Incorporated (NYSE: DGX) had its "outperform" rating re-affirmed by analysts at William Blair.
Show more
Ratings data for DGX provided by MarketBeat